300 related articles for article (PubMed ID: 23972643)
21. Predictive factors of malignancy in pediatric thyroid nodules.
Roy R; Kouniavsky G; Schneider E; Allendorf JD; Chabot JA; Logerfo P; Dackiw AP; Colombani P; Zeiger MA; Lee JA
Surgery; 2011 Dec; 150(6):1228-33. PubMed ID: 22136845
[TBL] [Abstract][Full Text] [Related]
22. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
[TBL] [Abstract][Full Text] [Related]
23. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
24. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
Zafón C; Obiols G; Mesa J
Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
[TBL] [Abstract][Full Text] [Related]
25. The association between serum TSH concentration and thyroid cancer.
Boelaert K
Endocr Relat Cancer; 2009 Dec; 16(4):1065-72. PubMed ID: 19620248
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of serum thyroid-stimulating hormone as indicator for fine-needle aspiration in patients with thyroid nodules.
Choi JS; Nam CM; Kim EK; Moon HJ; Han KH; Kwak JY
Head Neck; 2015 Apr; 37(4):498-504. PubMed ID: 24435826
[TBL] [Abstract][Full Text] [Related]
27. Refined use of scintigraphy in the evaluation of nodular thyroid disease.
McHenry CR; Slusarczyk SJ; Askari AT; Lange RL; Smith CM; Nekl K; Murphy TA
Surgery; 1998 Oct; 124(4):656-61; discussion 661-2. PubMed ID: 9780985
[TBL] [Abstract][Full Text] [Related]
28. Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients.
Baier ND; Hahn PF; Gervais DA; Samir A; Halpern EF; Mueller PR; Harisinghani MG
AJR Am J Roentgenol; 2009 Oct; 193(4):1175-9. PubMed ID: 19770344
[TBL] [Abstract][Full Text] [Related]
29. Inappropriate Suppression of Thyrotropin Concentrations in Young Patients with Thyroid Nodules Including Thyroid Cancer: The Fukushima Health Management Survey.
Suzuki S; Nakamura I; Suzuki S; Ohkouchi C; Mizunuma H; Midorikawa S; Fukushima T; Ito Y; Shimura H; Ohira T; Matsuzuka T; Ohtsuru A; Abe M; Yamashita S; Suzuki S
Thyroid; 2016 May; 26(5):717-25. PubMed ID: 26971545
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic features of thyroid nodules in pediatrics.
Corrias A; Mussa A; Baronio F; Arrigo T; Salerno M; Segni M; Vigone MC; Gastaldi R; Zirilli G; Tuli G; Beccaria L; Iughetti L; Einaudi S; Weber G; De Luca F; Cassio A;
Arch Pediatr Adolesc Med; 2010 Aug; 164(8):714-9. PubMed ID: 20679162
[TBL] [Abstract][Full Text] [Related]
31. [When and how to manage thyroid nodules?].
Procopiou M
Ther Umsch; 2011 Jun; 68(6):285-9. PubMed ID: 21656485
[TBL] [Abstract][Full Text] [Related]
32. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.
Haymart MR; Repplinger DJ; Leverson GE; Elson DF; Sippel RS; Jaume JC; Chen H
J Clin Endocrinol Metab; 2008 Mar; 93(3):809-14. PubMed ID: 18160464
[TBL] [Abstract][Full Text] [Related]
33. Serum TSH levels as a predictor of malignancy in thyroid nodules: A prospective study.
Golbert L; de Cristo AP; Faccin CS; Farenzena M; Folgierini H; Graudenz MS; Maia AL
PLoS One; 2017; 12(11):e0188123. PubMed ID: 29145466
[TBL] [Abstract][Full Text] [Related]
34. Epidemiological characteristics of thyroid nodules and risk factors for malignant nodules: a retrospective study from 6,304 surgical cases.
Huan Q; Wang K; Lou F; Zhang L; Huang Q; Han Y; Sun H; Zhu L; Lin P; Song J; Liu F; Wang Q; Hou W
Chin Med J (Engl); 2014; 127(12):2286-92. PubMed ID: 24931243
[TBL] [Abstract][Full Text] [Related]
35. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.
Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J
Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364
[TBL] [Abstract][Full Text] [Related]
36. [Thyroid nodule: benign or malignant?].
Liénart F
Rev Med Brux; 2012 Sep; 33(4):254-62. PubMed ID: 23091929
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of a thyroid nodule].
Tryggvason G; Briem B
Laeknabladid; 2017 Januar; 102(1):23-27. PubMed ID: 28497767
[TBL] [Abstract][Full Text] [Related]
38. Thyrotropin serum concentrations in patients with papillary thyroid microcancers.
Gerschpacher M; Göbl C; Anderwald C; Gessl A; Krebs M
Thyroid; 2010 Apr; 20(4):389-92. PubMed ID: 20210672
[TBL] [Abstract][Full Text] [Related]
39. Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease.
Saussez S; Glinoer D; Chantrain G; Pattou F; Carnaille B; André S; Gabius HJ; Laurent G
Thyroid; 2008 Jul; 18(7):705-12. PubMed ID: 18630998
[TBL] [Abstract][Full Text] [Related]
40. Differentiated Thyroid Cancer in Children: Prevalence and Predictors in a Large Cohort with Thyroid Nodules Followed Prospectively.
Papendieck P; Gruñeiro-Papendieck L; Venara M; Acha O; Cozzani H; Mateos F; Maglio S; Calcagno ML; Bergada I; Chiesa A
J Pediatr; 2015 Jul; 167(1):199-201. PubMed ID: 26117640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
